These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 24911615

  • 21. Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.
    Aoki J, Mintz GS, Weissman NJ, Mann JT, Cannon L, Greenberg J, Grube E, Masud AR, Koglin J, Mandinov L, Stone GW.
    JACC Cardiovasc Interv; 2008 Apr; 1(2):161-7. PubMed ID: 19463294
    [Abstract] [Full Text] [Related]

  • 22. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P.
    J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
    [Abstract] [Full Text] [Related]

  • 23. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.
    Di Lorenzo E, De Luca G, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G.
    JACC Cardiovasc Interv; 2009 Jun; 2(6):515-23. PubMed ID: 19539255
    [Abstract] [Full Text] [Related]

  • 24. Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.
    Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G, De Luca G.
    Am Heart J; 2009 Oct; 158(4):e43-50. PubMed ID: 19781402
    [Abstract] [Full Text] [Related]

  • 25. Neointimal tissue component assessed by tissue characterization with 40 MHz intravascular ultrasound imaging: comparison of drug-eluting stents and bare-metal stents.
    Tsujita K, Takaoka N, Kaikita K, Hokimoto S, Horio E, Sato K, Mizobe M, Nakayama N, Kojima S, Tayama S, Sugiyama S, Nakamura S, Ogawa H.
    Catheter Cardiovasc Interv; 2013 Dec 01; 82(7):1068-74. PubMed ID: 23460385
    [Abstract] [Full Text] [Related]

  • 26. Different Plaque Composition and Progression in Patients with Stable and Unstable Coronary Syndromes Evaluated by Cardiac CT.
    Dalager MG, Bøttcher M, Thygesen J, Andersen G, Bøtker HE.
    Biomed Res Int; 2015 Dec 01; 2015():401357. PubMed ID: 26339610
    [Abstract] [Full Text] [Related]

  • 27. Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION).
    Chechi T, Vittori G, Biondi Zoccai GG, Vecchio S, Falchetti E, Spaziani G, Baldereschi G, Giglioli C, Valente S, Margheri M.
    J Interv Cardiol; 2007 Aug 01; 20(4):282-91. PubMed ID: 17680858
    [Abstract] [Full Text] [Related]

  • 28. Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials.
    Pracon R, Opolski MP, Mintz GS, Pregowski J, Kruk M, Popma JJ, Mandinov L, Wang H, Ellis SG, Grube E, Dawkins KD, Stone GW, Weissman NJ.
    J Invasive Cardiol; 2014 Oct 01; 26(10):501-11. PubMed ID: 25274860
    [Abstract] [Full Text] [Related]

  • 29. The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans.
    Papafaklis MI, Bourantas CV, Theodorakis PE, Katsouras CS, Naka KK, Fotiadis DI, Michalis LK.
    JACC Cardiovasc Interv; 2010 Nov 01; 3(11):1181-9. PubMed ID: 21087755
    [Abstract] [Full Text] [Related]

  • 30. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.
    JACC Cardiovasc Interv; 2013 Oct 01; 6(10):1026-34. PubMed ID: 24055443
    [Abstract] [Full Text] [Related]

  • 31. Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus.
    Kimura M, Mintz GS, Weissman NJ, Dawkins KD, Grube E, Ellis SG, Cannon LA, Masud Z, Mandinov L, Baim D, Stone GW.
    Am J Cardiol; 2008 May 01; 101(9):1263-8. PubMed ID: 18435955
    [Abstract] [Full Text] [Related]

  • 32. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).
    Dong L, Mintz GS, Witzenbichler B, Metzger DC, Rinaldi MJ, Duffy PL, Weisz G, Stuckey TD, Brodie BR, Yun KH, Xu K, Kirtane AJ, Stone GW, Maehara A.
    Am J Cardiol; 2015 Apr 01; 115(7):860-6. PubMed ID: 25661569
    [Abstract] [Full Text] [Related]

  • 33. Impact of advanced age on the safety and effectiveness of paclitaxel-eluting stent implantation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: The HORIZONS-AMI trial.
    Dudek D, Mehran R, Dziewierz A, Witzenbichler B, Brodie BR, Kornowski R, Fahy M, Lansky AJ, Rakowski T, Legutko J, Bryniarski L, Stone GW.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):869-77. PubMed ID: 23359554
    [Abstract] [Full Text] [Related]

  • 34. Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.
    Otake H, Honda Y, Courtney BK, Shimohama T, Ako J, Waseda K, Macours N, Rogers C, Popma JJ, Abizaid A, Ormiston JA, Spaulding C, Cohen SA, Fitzgerald PJ.
    Circ Cardiovasc Interv; 2011 Apr 01; 4(2):146-54. PubMed ID: 21386089
    [Abstract] [Full Text] [Related]

  • 35. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
    Ellis SG, Stone GW, Cox DA, Hermiller J, O'Shaughnessy C, Mann T, Turco M, Caputo R, Bergin PJ, Bowman TS, Baim DS, TAXUS IV Investigators.
    JACC Cardiovasc Interv; 2009 Dec 01; 2(12):1248-59. PubMed ID: 20129552
    [Abstract] [Full Text] [Related]

  • 36. Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials).
    Aoki J, Mintz GS, Weissman NJ, Mandinov L, Grube E, Dawkins KD, Ellis SG, Greenberg J, Yu A, Mann JT, Cannon L, Cambier PA, Stone GW.
    Am J Cardiol; 2008 Oct 15; 102(8):1009-16. PubMed ID: 18929701
    [Abstract] [Full Text] [Related]

  • 37. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D, Scheller B, Schäfer A, Klein G, Böhm M, Clever Y, Cremers B.
    EuroIntervention; 2012 Aug 15; 8(4):450-5. PubMed ID: 22917728
    [Abstract] [Full Text] [Related]

  • 38. Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial.
    Zhao Z, Witzenbichler B, Mintz GS, Jaster M, Choi SY, Wu X, He Y, Margolis MP, Dressler O, Cristea E, Parise H, Mehran R, Stone GW, Maehara A.
    JACC Cardiovasc Imaging; 2013 Jan 15; 6(1):86-95. PubMed ID: 23328566
    [Abstract] [Full Text] [Related]

  • 39. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ, ENDEAVOR IV Trial Investigators.
    JACC Cardiovasc Interv; 2009 Aug 15; 2(8):779-84. PubMed ID: 19695548
    [Abstract] [Full Text] [Related]

  • 40. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial.
    Guagliumi G, Costa MA, Sirbu V, Musumeci G, Bezerra HG, Suzuki N, Matiashvili A, Lortkipanidze N, Mihalcsik L, Trivisonno A, Valsecchi O, Mintz GS, Dressler O, Parise H, Maehara A, Cristea E, Lansky AJ, Mehran R, Stone GW.
    Circulation; 2011 Jan 25; 123(3):274-81. PubMed ID: 21220730
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.